Agios Pharmaceuticals AGIO
NASDAQ AGIO
$31.76 +0.38 (+1.21%)
At close: Nov 10, 2026 · 4:00 PM EST

Agios Pharmaceuticals (AGIO) EV to FCF (2016)

Updated

Agios Pharmaceuticals' EV to FCF came in at 42.61 for Q4 2016, up 25.7% from the prior quarter.

Analysis

Agios Pharmaceuticals (AGIO) EV to FCF (2016) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Agios Pharmaceuticals 1.90 Bn -940.41 Mn 52.86 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2016 42.61
Sep 30, 2016 33.90
Jun 30, 2016 15.51
API Access

Agios Pharmaceuticals EV to FCF API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-fcf&ticker=AGIO&period=max&api_key=YOUR_API_KEY